Differential effects of substrate modulus on human vascular endothelial, smooth muscle, and fibroblastic cells

Journal of Biomedical Materials Research - Part A

Volumn 100 A, Issue 5, 2012, Pages 1356-1367

  Robinson, Karyn G ^a   Nie, Ting ^b   Baldwin, Aaron D ^b   Yang, Elaine C ^a   Kiick, Kristi L ^b,c   Akins Jr , Robert E ^a  

^a NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^b DUPONT COMPANY   (United States)

^c UNIVERSITY OF DELAWARE   (United States)

Author keywords

cell proliferation; gene expression; modulus; PEG hydrogels; vascular cells

Indexed keywords

CELL TYPES; DIFFERENTIAL EFFECT; FIBROBLASTIC CELLS; GENE EXPRESSION PROFILES; GROWTH FACTOR; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMAN VASCULAR SMOOTH MUSCLE CELLS; MODULUS; PEG HYDROGEL; PEG HYDROGELS; PREFERENTIAL ATTACHMENTS; PREFERENTIAL GROWTH; REGENERATIVE MEDICINE; SMOOTH MUSCLES; VASCULAR CELLS; VASCULAR RECONSTRUCTION;

BIOLOGICAL MATERIALS; BIOMATERIALS; BIOMECHANICS; CELL CULTURE; CELL PROLIFERATION; ENDOTHELIAL CELLS; GENE EXPRESSION; MECHANICAL PROPERTIES; POLYETHYLENE GLYCOLS; POPULATION STATISTICS;

HYDROGELS;

CXCL1 CHEMOKINE; FIBRONECTIN; GROWTH FACTOR; INTERLEUKIN 1BETA; INTERLEUKIN 8; LOW MOLECULAR WEIGHT HEPARIN; MACROGOL; VASCULOTROPIN;

ARTICLE; CELL ADHESION; CELL DENSITY; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CONTROLLED STUDY; FIBROBLAST; GELATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HYDROGEL; SMOOTH MUSCLE FIBER; UMBILICAL VEIN ENDOTHELIAL CELL;

ANIMALS; CELL ADHESION; CELL PROLIFERATION; CELL SHAPE; CLUSTER ANALYSIS; ELASTIC MODULUS; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROGEL; MICE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NIH 3T3 CELLS; OSCILLOMETRY; RHEOLOGY;

EID: 84859108261     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.34075     Document Type: Article

References (101)

1. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR,. Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 1996; 28: 616-626. (Pubitemid 26288642)
2. Motwani JG, Topol EJ,. Aortocoronary saphenous vein graft disease: Pathogenesis, predisposition, and prevention. Circulation 1998; 97: 916-931. (Pubitemid 28113931)
3. Peyton SR, Raub CB, Keschrumrus VP, Putnam AJ,. The use of poly(ethylene glycol) hydrogels to investigate the impact of ECM chemistry and mechanics on smooth muscle cells. Biomaterials 2006; 27: 4881-4893. (Pubitemid 43866921)
4. Shinoka T, Breuer C,. Tissue-engineered blood vessels in pediatric cardiac surgery. Yale J Biol Med 2008; 81: 161-166.
5. Zhang WJ, Liu W, Cui L, Cao Y,. Tissue engineering of blood vessel. J Cell Mol Med 2007; 11: 945-957.
6. Chien S, Li S, Shyy YJ,. Effects of mechanical forces on signal transduction and gene expression in endothelial cells. Hypertension 1998; 31 (1 Part 2): 162-169.
7. Stegemann JP, Hong H, Nerem RM,. Mechanical, biochemical, and extracellular matrix effects on vascular smooth muscle cell phenotype. J Appl Physiol 2005; 98: 2321-2327. (Pubitemid 40726933)
8. Dzau VJ, Braun-Dullaeus RC, Sedding DG,. Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies. Nat Med 2002; 8: 1249-1256. (Pubitemid 35373556)
9. Jiang Z, Yu P, Tao M, Fernandez C, Ifantides C, Moloye O, Schultz GS, Ozaki CK, Berceli SA,. TGF-β- and CTGF-mediated fibroblast recruitment influences early outward vein graft remodeling. Am J Physiol Heart Circ Physiol 2007; 293: H482-H488. (Pubitemid 47105106)
10. Sartore S, Chiavegato A, Faggin E, Franch R, Puato M, Ausoni S, Pauletto P,. Contribution of adventitial fibroblasts to neointima formation and vascular remodeling: From innocent bystander to active participant. Circ Res 2001; 89: 1111-1121. (Pubitemid 34627868)
11. Bryant SJ, Anseth KS,. Hydrogel properties influence ECM production by chondrocytes photoencapsulated in poly(ethylene glycol) hydrogels. J Biomed Mater Res 2002; 59: 63-72.
12. Bryant SJ, Anseth KS,. Controlling the spatial distribution of ECM components in degradable PEG hydrogels for tissue engineering cartilage. J Biomed Mater Res A 2003; 64: 70-79. (Pubitemid 37521468)
13. Burdick JA, Anseth KS,. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials 2002; 23: 4315-4323.
14. Elisseeff J, Anseth K, Sims D, McIntosh W, Randolph M, Langer R,. Transdermal photopolymerization for minimally invasive implantation. Proc Natl Acad Sci USA 1999; 96: 3104-3107. (Pubitemid 29148851)
15. Mann BK, Gobin AS, Tsai AT, Schmedlen RH, West JL,. Smooth muscle cell growth in photopolymerized hydrogels with cell adhesive and proteolytically degradable domains: Synthetic ECM analogs for tissue engineering. Biomaterials 2001; 22: 3045-3051. (Pubitemid 32768712)
16. Mann BK, West JL,. Cell adhesion peptides alter smooth muscle cell adhesion, proliferation, migration, and matrix protein synthesis on modified surfaces and in polymer scaffolds. J Biomed Mater Res 2002; 60: 86-93. (Pubitemid 34126989)
17. Almany L, Seliktar D,. Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures. Biomaterials 2005; 26: 2467-2477. (Pubitemid 39600699)
18. Lutolf MP, Hubbell JA,. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005; 23: 47-55. (Pubitemid 41724624)
19. Nguyen KT, West JL,. Photopolymerizable hydrogels for tissue engineering applications. Biomaterials 2002; 23: 4307-4314.
20. Hern DL, Hubbell JA,. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J Biomed Mater Res 1998; 39: 266-276. (Pubitemid 28060360)
21. Raeber GP, Lutolf MP, Hubbell JA,. Molecularly engineered PEG hydrogels: A novel model system for proteolytically mediated cell migration. Biophys J 2005; 89: 1374-1388. (Pubitemid 41099019)
22. Peyton SR, Kim PD, Ghajar CM, Seliktar D, Putnam AJ,. The effects of matrix stiffness and RhoA on the phenotypic plasticity of smooth muscle cells in a 3-D biosynthetic hydrogel system. Biomaterials 2008; 29: 2597-2607.
23. DeLong SA, Moon JJ, West JL,. Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration. Biomaterials 2005; 26: 3227-3234. (Pubitemid 39647256)
24. Gobin AS, West JL,. Val-ala-pro-gly, an elastin-derived non-integrin ligand: Smooth muscle cell adhesion and specificity. J Biomed Mater Res A 2003; 67: 255-259. (Pubitemid 37517175)
25. Boontheekul T, Mooney DJ,. Protein-based signaling systems in tissue engineering. Curr Opin Biotechnol 2003; 14: 559-565. (Pubitemid 37298044)
26. Kleinman HK, Philp D, Hoffman MP,. Role of the extracellular matrix in morphogenesis. Curr Opin Biotechnol 2003; 14: 526-532. (Pubitemid 37298039)
27. Cai S, Liu Y, Zheng Shu X, Prestwich GD,. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials 2005; 26: 6054-6067. (Pubitemid 40805611)
28. Pratt AB, Weber FE, Schmoekel HG, Muller R, Hubbell JA,. Synthetic extracellular matrices for in situ tissue engineering. Biotechnol Bioeng 2004; 86: 27-36. (Pubitemid 38339388)
29. Sakiyama-Elbert SE, Hubbell JA,. Development of fibrin derivatives for controlled release of heparin-binding growth factors. J Control Release 2000; 65: 389-402. (Pubitemid 30122941)
30. Tae G, Scatena M, Stayton PS, Hoffman AS,. PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor. J Biomater Sci Polym Ed 2006; 17: 187-197. (Pubitemid 44069724)
31. Yamaguchi N, Zhang L, Chae BS, Palla CS, Furst EM, Kiick KL,. Growth factor mediated assembly of cell receptor-responsive hydrogels. J Am Chem Soc 2007; 129: 3040-3041. (Pubitemid 46449311)
32. Nie T, Baldwin A, Yamaguchi N, Kiick KL,. Production of heparin-functionalized hydrogels for the development of responsive and controlled growth factor delivery systems. J Control Release 2007; 122: 287-296. (Pubitemid 47404668)
33. Schultz KM, Baldwin AD, Kiick KL, Furst EM,. Gelation of covalently cross-linked PEG-heparin hydrogels. Macromolecules 2009; 42: 5310-5316.
34. Nie T, Akins RE Jr, Kiick KL,. Production of heparin-containing hydrogels for modulating cell responses. Acta Biomater 2009; 5: 865-875.
35. Engler AJ, Griffin MA, Sen S, Bonnemann CG, Sweeney HL, Discher DE,. Myotubes differentiate optimally on substrates with tissue-like stiffness: Pathological implications for soft or stiff microenvironments. J Cell Biol 2004; 166: 877-887. (Pubitemid 39249838)
36. Ghosh K, Pan Z, Guan E, Ge S, Liu Y, Nakamura T, Ren XD, Rafailovich M, Clark RA,. Cell adaptation to a physiologically relevant ECM mimic with different viscoelastic properties. Biomaterials 2007; 28: 671-679. (Pubitemid 44647459)
37. Banerjee A, Arha M, Choudhary S, Ashton RS, Bhatia SR, Schaffer DV, Kane RS,. The influence of hydrogel modulus on the proliferation and differentiation of encapsulated neural stem cells. Biomaterials 2009; 30: 4695-4699.
38. Flanagan LA, Ju YE, Marg B, Osterfield M, Janmey PA,. Neurite branching on deformable substrates. Neuroreport 2002; 13: 2411-2415. (Pubitemid 36143534)
39. Saha K, Keung AJ, Irwin EF, Li Y, Little L, Schaffer DV, Healy KE,. Substrate modulus directs neural stem cell behavior. Biophys J 2008; 95: 4426-4438.
40. Subramanian A, Lin HY,. Crosslinked chitosan: Its physical properties and the effects of matrix stiffness on chondrocyte cell morphology and proliferation. J Biomed Mater Res A 2005; 75: 742-753. (Pubitemid 47233458)
41. Osol G,. Mechanotransduction by vascular smooth muscle. J Vasc Res 1995; 32: 275-292.
42. Kim BS, Nikolovski J, Bonadio J, Mooney DJ,. Cyclic mechanical strain regulates the development of engineered smooth muscle tissue. Nat Biotechnol 1999; 17: 979-983. (Pubitemid 29474853)
43. Williams B,. Mechanical influences on vascular smooth muscle cell function. J Hypertens 1998; 16 (12 Part 2): 1921-1929. (Pubitemid 29002369)
44. Mammoto A, Connor KM, Mammoto T, Yung CW, Huh D, Aderman CM, Mostoslavsky G, Smith LE, Ingber DE,. A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature 2009; 457: 1103-1108.
45. Munoz-Pinto DJ, Bulick AS, Hahn MS,. Uncoupled investigation of scaffold modulus and mesh size on smooth muscle cell behavior. J Biomed Mater Res A 2009; 90: 303-316.
46. Collinsworth AM, Zhang S, Kraus WE, Truskey GA,. Apparent elastic modulus and hysteresis of skeletal muscle cells throughout differentiation. Am J Physiol Cell Physiol 2002; 283: C1219-C1227.
47. Levental I, Georges PC, Janmey PA,. Soft biological materials and their impact on cell function. Soft Matter 2006; 2: 1-9.
48. Taylor Z, Miller K,. Reassessment of brain elasticity for analysis of biomechanisms of hydrocephalus. J Biomech 2004; 37: 1263-1269. (Pubitemid 38798381)
49. Jin W, Riley RM, Wolfinger RD, White KP, Passador-Gurgel G, Gibson G,. The contributions of sex, genotype and age to transcriptional variance in Drosophila melanogaster. Nat Genet 2001; 29: 389-395. (Pubitemid 34326688)
50. Kendziorski C, Irizarry RA, Chen KS, Haag JD, Gould MN,. On the utility of pooling biological samples in microarray experiments. Proc Natl Acad Sci USA 2005; 102: 4252-4257. (Pubitemid 40397098)
51. Saban MR, Hellmich H, Nguyen NB, Winston J, Hammond TG, Saban R,. Time course of LPS-induced gene expression in a mouse model of genitourinary inflammation. Physiol Genomics 2001; 5: 147-160. (Pubitemid 33675212)
52. Agrawal D, Chen T, Irby R, Quackenbush J, Chambers AF, Szabo M, Cantor A, Coppola D, Yeatman TJ,. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling. J Natl Cancer Inst 2002; 94: 513-521. (Pubitemid 34411290)
53. Rutledge RG, Stewart D,. A kinetic-based sigmoidal model for the polymerase chain reaction and its application to high-capacity absolute quantitative real-time PCR. BMC Biotechnol 2008; 8: 47.
54. Pfaffl MW,. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
55. Quackenbush J,. Microarray data normalization and transformation. Nat Genet 2002; 32 Suppl: 496-501. (Pubitemid 35435152)
56. Bray I, Bryan K, Prenter S, Buckley PG, Foley NH, Murphy DM, Alcock L, Mestdagh P, Vandesompele J, Speleman F, et al. Widespread dysregulation of MiRNAs by MYCN amplification and chromosomal imbalances in neuroblastoma: Association of miRNA expression with survival. PLoS One 2009; 4: e7850.
57. Benoit DS, Anseth KS,. Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation. Acta Biomater 2005; 1: 461-470. (Pubitemid 43348782)
58. Yamaguchi N, Chae BS, Zhang L, Kiick KL, Furst EM,. Rheological characterization of polysaccharide-poly(ethylene glycol) star copolymer hydrogels. Biomacromolecules 2005; 6: 1931-1940. (Pubitemid 41052186)
59. Yamaguchi N, Kiick KL,. Polysaccharide-poly(ethylene glycol) star copolymer as a scaffold for the production of bioactive hydrogels. Biomacromolecules 2005; 6: 1921-1930. (Pubitemid 41052185)
60. Yamaguchi N, Zhang L, Chae BS, Palla CS, Furst EM, Kiick KL,. Growth factor mediated assembly of cell receptor-responsive hydrogels. J Am Chem Soc 2007; 129: 3040-3041. (Pubitemid 46449311)
61. Schultz KM, Baldwin AD, Kiick KL, Furst EM,. Rapid rheological screening to identify conditions of biomaterial hydrogelation. Soft Matter 2009; 5: 740-742.
62. Hasegawa T, Kimura A, Miyataka M, Inagaki M, Ishikawa K,. Basic fibroblast growth factor increases regional myocardial blood flow and salvages myocardium in the infarct border zone in a rabbit model of acute myocardial infarction. Angiology 1999; 50: 487-495. (Pubitemid 29277603)
63. Hughes GC, Biswas SS, Yin B, Coleman RE, DeGrado TR, Landolfo CK, Lowe JE, Annex BH, Landolfo KP,. Therapeutic angiogenesis in chronically ischemic porcine myocardium: Comparative effects of bFGF and VEGF. Ann Thorac Surg 2004; 77: 812-818. (Pubitemid 38292073)
64. Losordo DW, Vale PR, Hendel RC, Milliken CE, Fortuin FD, Cummings N, Schatz RA, Asahara T, Isner JM, Kuntz RE,. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 2002; 105: 2012-2018. (Pubitemid 34465261)
65. Okumura M, Okuda T, Nakamura T, Yajima M,. Acceleration of wound healing in diabetic mice by basic fibroblast growth factor. Biol Pharm Bull 1996; 19: 530-535. (Pubitemid 26144609)
66. Ruel M, Laham RJ, Parker JA, Post MJ, Ware JA, Simons M, Sellke FW,. Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. J Thorac Cardiovasc Surg 2002; 124: 28-34.
67. Wilcke I, Lohmeyer JA, Liu S, Condurache A, Kruger S, Mailander P, Machens HG,. VEGF(165) and bFGF protein-based therapy in a slow release system to improve angiogenesis in a bioartificial dermal substitute in vitro and in vivo. Langenbecks Arch Surg 2007; 392: 305-314. (Pubitemid 46675815)
68. Nuttelman CR, Mortisen DJ, Henry SM, Anseth KS,. Attachment of fibronectin to poly(vinyl alcohol) hydrogels promotes NIH3T3 cell adhesion, proliferation, and migration. J Biomed Mater Res 2001; 57: 217-223. (Pubitemid 32988500)
69. McDonald JA, Kelley DG,. Degradation of fibronectin by human leukocyte elastase. Release of biologically active fragments. J Biol Chem 1980; 255: 8848-8858. (Pubitemid 11211537)
70. Wagner DD, Hynes RO,. Domain structure of fibronectin and its relation to function. Disulfides and sulfhydryl groups. J Biol Chem 1979; 254: 6746-6754. (Pubitemid 10225635)
71. Dahl SL, Rhim C, Song YC, Niklason LE,. Mechanical properties and compositions of tissue engineered and native arteries. Ann Biomed Eng 2007; 35: 348-355. (Pubitemid 46325722)
72. Miqin Z, Desai T, Ferrari M,. Proteins and cells on PEG immobilized silicon surfaces. Biomaterials 1998; 19: 953-960. (Pubitemid 28327525)
73. Ghosh K, Ren XD, Shu XZ, Prestwich GD, Clark RA,. Fibronectin functional domains coupled to hyaluronan stimulate adult human dermal fibroblast responses critical for wound healing. Tissue Eng 2006; 12: 601-613. (Pubitemid 43673465)
74. Ji Y, Ghosh K, Li B, Sokolov JC, Clark RA, Rafailovich MH,. Dual-syringe reactive electrospinning of cross-linked hyaluronic acid hydrogel nanofibers for tissue engineering applications. Macromol Biosci 2006; 6: 811-817. (Pubitemid 44831726)
75. Kurihara H, Nagamune T,. Cell adhesion ability of artificial extracellular matrix proteins containing a long repetitive Arg-Gly-Asp sequence. J Biosci Bioeng 2005; 100: 82-87. (Pubitemid 41569350)
76. Yan H, Saiani A, Gough JE, Miller AF,. Thermoreversible protein hydrogel as cell scaffold. Biomacromolecules 2006; 7: 2776-2782. (Pubitemid 44615260)
77. Broderick EP, O'Halloran DM, Rochev YA, Griffin M, Collighan RJ, Pandit AS,. Enzymatic stabilization of gelatin-based scaffolds. J Biomed Mater Res B Appl Biomater 2005; 72: 37-42. (Pubitemid 40039607)
78. Linnes MP, Ratner BD, Giachelli CM,. A fibrinogen-based precision microporous scaffold for tissue engineering. Biomaterials 2007; 28: 5298-5306. (Pubitemid 47534237)
79. Sieminski AL, Was AS, Kim G, Gong H, Kamm RD,. The stiffness of three-dimensional ionic self-assembling peptide gels affects the extent of capillary-like network formation. Cell Biochem Biophys 2007; 49: 73-83. (Pubitemid 47574999)
80. Jung JP, Jones JL, Cronier SA, Collier JH,. Modulating the mechanical properties of self-assembled peptide hydrogels via native chemical ligation. Biomaterials 2008; 29: 2143-2151.
81. Chaudhuri S, Vyas K, Kapasi P, Komar AA, Dinman JD, Barik S, Mazumder B,. Human ribosomal protein L13a is dispensable for canonical ribosome function but indispensable for efficient rRNA methylation. RNA 2007; 13: 2224-2237. (Pubitemid 350127563)
82. Mazumder B, Sampath P, Seshadri V, Maitra RK, DiCorleto PE, Fox PL,. Regulated release of L13a from the 60S ribosomal subunit as a mechanism of transcript-specific translational control. Cell 2003; 115: 187-198. (Pubitemid 37329582)
83. Goldie LC, Nix MK, Hirschi KK,. Embryonic vasculogenesis and hematopoietic specification. Organogenesis 2008; 4: 257-263.
84. Volpert OV, Lawler J, Bouck NP,. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1. Proc Natl Acad Sci USA 1998; 95: 6343-6348. (Pubitemid 28249014)
85. Tieu BC, Lee C, Sun H, Lejeune W, Recinos A III, Ju X, Spratt H, Guo DC, Milewicz D, Tilton RG, et al. An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J Clin Invest 2009; 119: 3637-3651.
86. Gonzalez-Navarro H, Vinue A, Vila-Caballer M, Fortuno A, Beloqui O, Zalba G, Burks D, Diez J, Andres V,. Molecular mechanisms of atherosclerosis in metabolic syndrome: Role of reduced IRS2-dependent signaling. Arterioscler Thromb Vasc Biol 2008; 28: 2187-2194.
87. Petrovic N, Bhagwat SV, Ratzan WJ, Ostrowski MC, Shapiro LH,. CD13/APN transcription is induced by RAS/MAPK-mediated phosphorylation of Ets-2 in activated endothelial cells. J Biol Chem 2003; 278: 49358-49368.
88. Sakurai D, Tsuchiya N, Yamaguchi A, Okaji Y, Tsuno NH, Kobata T, Takahashi K, Tokunaga K,. Crucial role of inhibitor of DNA binding/ differentiation in the vascular endothelial growth factor-induced activation and angiogenic processes of human endothelial cells. J Immunol 2004; 173: 5801-5809. (Pubitemid 39392170)
89. Breen EC,. VEGF in biological control. J Cell Biochem 2007; 102: 1358-1367. (Pubitemid 350223939)
90. Wang D, Sai J, Carter G, Sachpatzidis A, Lolis E, Richmond A,. PAK1 kinase is required for CXCL1-induced chemotaxis. Biochemistry 2002; 41: 7100-7107. (Pubitemid 34575683)
91. Dallon JC, Ehrlich HP,. A review of fibroblast-populated collagen lattices. Wound Repair Regen 2008; 16: 472-479. (Pubitemid 352000311)
92. Qian S, Somlo G, Zhou B, Zhu L, Mi S, Mo X, Cheung EM, Qiu W, Lin RJ, Rossi J, et al. Ribozyme cleavage leads to decreased expression of fibroblast growth factor receptor 3 in human multiple myeloma cells, which is associated with apoptosis and downregulation of vascular endothelial growth factor. Oligonucleotides 2005; 15: 1-11. (Pubitemid 40411521)
93. Stetler-Stevenson WG,. Tissue inhibitors of metalloproteinases in cell signaling: Metalloproteinase-independent biological activities. Sci Signal 2008; 1: re6.
94. Holderfield MT, Hughes CC,. Crosstalk between vascular endothelial growth factor, notch, and transforming growth factor-β in vascular morphogenesis. Circ Res 2008; 102: 637-652. (Pubitemid 351457853)
95. Goumans MJ, Lebrin F, Valdimarsdottir G,. Controlling the angiogenic switch: A balance between two distinct TGF-b receptor signaling pathways. Trends Cardiovasc Med 2003; 13: 301-307. (Pubitemid 37159396)
96. Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR, Massague J,. TGFβ primes breast tumors for lung metastasis seeding through angiopoietin-like 4. Cell 2008; 133: 66-77. (Pubitemid 351442989)
97. Yang YH, Wang Y, Lam KS, Yau MH, Cheng KK, Zhang J, Zhu W, Wu D, Xu A,. Suppression of the Raf/MEK/ERK signaling cascade and inhibition of angiogenesis by the carboxyl terminus of angiopoietin-like protein 4. Arterioscler Thromb Vasc Biol 2008; 28: 835-840. (Pubitemid 351544096)
98. Bornstein P,. Thrombospondins function as regulators of angiogenesis. J Cell Commun Signal 2009; 3: 189-200.
99. Kim HY, Kang YJ, Song IH, Choi HC, Kim HS,. Upregulation of interleukin-8/CXCL8 in vascular smooth muscle cells from spontaneously hypertensive rats. Hypertens Res 2008; 31: 515-523. (Pubitemid 351597506)
100. Wang Z, Castresana MR, Newman WH,. NF-;B is required for TNF-α-directed smooth muscle cell migration. FEBS Lett 2001; 508: 360-364. (Pubitemid 33135471)
101. Weber DS,. A novel mechanism of vascular smooth muscle cell regulation by Notch: Platelet-derived growth factor receptor-β expression? Circ Res 2008; 102: 1448-1450.